단계 미표기모집 중단 (진행 중)
Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®
연구 개요
Participants are invited to take part in this study because they have AGHD (only severe case). The purpose of this study is to assess long term safety and effectiveness of Sogroya® in patients with AGHD (only severe case) under normal clinical practice condition in Japan. Participants will get Sogroya® as prescribed by the study doctor. Participants will be in the study for about 2 to 5 years depending on when they take part in the study. Participants will be asked to fill in the quality of life questionnaires.
- 스폰서
- 리드: 노보노디스크
- 적응증
- Adult Growth Hormone Deficiency
- 중재
- Somapacitan
- 목표 등록
- 200명
- 시작일
- 2022-02-03
- 완료(예정)
- 2026-12-31
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.